When is a pathology review indicated in endometrial cancer?

Obstetrics and Gynecology

Volumn 110, Issue 6, 2007, Pages 1224-1230

  Kwon, Janice S ^a   Francis, Julie A ^b   Qiu, Feng ^b   Weir, Michele M ^b   Ettler, Helen C ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOMETRIUM CANCER; ENDOMETRIUM SARCOMA; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTICENTER STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; TERTIARY HEALTH CARE; CANADA; CLASSIFICATION; COHORT ANALYSIS; DISEASE COURSE; ENDOMETRIUM TUMOR; MEDICAL AUDIT; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; STANDARD; TUMOR RECURRENCE;

AGED; COHORT STUDIES; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVER VARIATION; ONTARIO; PATHOLOGY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 38449087181     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000287618.86078.6c     Document Type: Article

References (33)

1. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-27.
2. Carey MS, O'Connell GJ, Johanson CR, Goodyear MD, Murphy KJ, Daya DM, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995;57:138-44.
3. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11.
4. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51.
5. Chafe S, Honore L, Pearcey R, Capstick V. An analysis of the impact of pathology review in gynecologic cancer. Int J Radiat Oncol Biol Phys 2000;48:1433-8.
6. PORTEC. PORTEC-2: Postoperative Radiation Therapy for Endometrial Carcinoma - a multicenter randomised phase III trial comparing external beam radiation and vaginal brachy-therapy. Available at: http://www.trialregister.nl/ trialreg/admin/rctview.asp?TC=332. Retrieved October 10, 2007.
7. Kwon JS, Carey MS, Cook EF, Qiu F, Paszat L. Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study. Int J Gynecol Cancer 2007;17:433-40.
8. National Cancer Comprehensive Network. Practice Guidelines in Oncology: Uterine Neoplasms. Available at: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp#site. Retrieved October 10, 2007.
9. Ali A, Black D, Soslow RA. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 2007;26:115-23.
10. Jacques SM, Qureshi F, Munkarah A, Lawrence WD. Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens. Int J Gynecol Pathol 1998;17:42-5.
11. Scholten AN, van Putten WL, Beerman H, Smit VT, Koper PC, Lybeert ML, et al. Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 2005;63:834-8.
12. Alkushi A, Abdul-Rahman ZH, Lim P, Schulzer M, Coldman A, Kalloger SE, et al. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol 2005;29:295-304.
13. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000;24:1201-8.
14. Scholten AN, Smit VT, Beerman H, van Putten WL, Creutzberg CL. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer 2004;100:764-72.
15. Taylor RR, Lieberman RW, O'Connor DM. An analysis of two versus three grades for endometrial carcinoma. Gynecol Oncol 1999;74:3-6.
16. Abeler VM, Kjorstad KE. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. Gynecol Oncol 1990;39:266-71.
17. Abeler VM, Kjorstad KE. Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases. Gynecol Oncol 1991;40:207-17.
18. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93-108.
19. Khalifa MA, Dodge J, Covens A, Osborne R, Ackerman I. Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. Gynecol Oncol 2003;90:425-30.
20. Santoso JT, Coleman RL, Voet RL, Bernstein SG, Lifshitz S, Miller D. Pathology slide review in gynecologic oncology. Obstet Gynecol 1998;91:730-4.
21. Selman AE, Niemann TH, Fowler JM, Copeland LJ. Quality assurance of second opinion pathology in gynecologic oncology. Obstetrics and gynecology 1999;94:302-6.
22. Statistics Canada. Census 2001. Population and Dwelling Counts for Canada, Provinces, and Territories, 2001 and 1996 Censuses-100% Data. Available at: http://www.census2006.ca/english/census01/products/standard/popdwell/Table- PR.cfm Retrieved September 5, 2007.
23. Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:804-11.
24. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2nd, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:812-9.
25. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006;24:36-44.
26. Orton J. Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: Results of the randomised MRC-ASTEC and NCIC CTG EN.5 trial. J Clin Oncol 2007;25:18S.
27. Canada Post. Postal guide. Prices. Available at: http://www.canadapost. ca/personal/tools/pg/prices/CPcanada-e.asp#1391876. Retrieved September 5, 2007.
28. Ontario Ministry of Health and Long-Term Care. Schedule of benefits for physician services under the health insurance act. Available at: http://www.health.gov.on.ca/english/providers/program/ohip/sob/physserv/ physserv_mn.html. Retrieved September 5, 2007.
29. Job futures: secretaries, recorders, and transcriptionists. Available at: http://www.jobfutures.ca.noc/124.shtml. Retrieved October 10, 2007.
30. Canadian Cancer Society. Canadian cancer statistics: geographic patterns of cancer occurrence. Available at: http://www.cancer.ca/ccs/internet/standard/ 0,3182,3172_14279_langId-en,00.html. Retrieved October 10, 2007.
31. Aalders JG, Thomas G. Endometrial cancer - revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 2007;104:222-31.
32. Hogberg T, Fredstorp-Lidebring M, Alm P, Baldetorp B, Larsson G, Ottosen C, et al. A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer. Int J Gynecol Cancer 2004;14:437-50.
33. Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 1996;60:177-83.